Opus Genetics (IRD) Institutional Ownership $0.95 +0.02 (+1.75%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$0.96 +0.01 (+0.59%) As of 05/2/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Opus Genetics (NASDAQ:IRD)CurrentInstitutional OwnershipPercentage14.97%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$27.58KNumber ofInstitutional Sellers(last 12 months)0 Get IRD Insider Trade Alerts Want to know when executives and insiders are buying or selling Opus Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Opus Genetics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2025 Apollon Wealth Management LLC28,089$28K0.0%N/A0.062% (Data available from 1/1/2016 forward) IRD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IRD shares? During the previous two years, the following institutional investors and hedge funds held shares of Opus Genetics shares: Apollon Wealth Management LLC ($28K).Learn more on IRD's institutional investors. What percentage of Opus Genetics stock is owned by institutional investors? 14.97% of Opus Genetics stock is owned by institutional investors. Learn more on IRD's institutional investor holdings. Which institutional investors have been buying Opus Genetics stock? The following institutional investors have purchased Opus Genetics stock in the last 24 months: Apollon Wealth Management LLC ($28.09K). How much institutional buying is happening at Opus Genetics? Institutional investors have bought a total of 28,089 shares in the last 24 months. This purchase volume represents approximately $27.58K in transactions. Related Companies 4D Molecular Therapeutics Major Shareholders Tiziana Life Sciences Major Shareholders LifeVantage Major Shareholders Larimar Therapeutics Major Shareholders Nanobiotix Major Shareholders Puma Biotechnology Major Shareholders Cybin Major Shareholders Aclaris Therapeutics Major Shareholders Eupraxia Pharmaceuticals Major Shareholders ADC Therapeutics Major Shareholders This page (NASDAQ:IRD) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
